Metabolic Engineering, VTT Technical Research Centre of Finland, Espoo, Finland.
PLoS One. 2012;7(4):e35450. doi: 10.1371/journal.pone.0035450. Epub 2012 Apr 10.
Fungal secondary metabolites are a rich source of medically useful compounds due to their pharmaceutical and toxic properties. Sequencing of fungal genomes has revealed numerous secondary metabolite gene clusters, yet products of many of these biosynthetic pathways are unknown since the expression of the clustered genes usually remains silent in normal laboratory conditions. Therefore, to discover new metabolites, it is important to find ways to induce the expression of genes in these otherwise silent biosynthetic clusters. We discovered a novel secondary metabolite in Aspergillus nidulans by predicting a biosynthetic gene cluster with genomic mining. A Zn(II)(2)Cys(6)-type transcription factor, PbcR, was identified, and its role as a pathway-specific activator for the predicted gene cluster was demonstrated. Overexpression of pbcR upregulated the transcription of seven genes in the identified cluster and led to the production of a diterpene compound, which was characterized with GC/MS as ent-pimara-8(14),15-diene. A change in morphology was also observed in the strains overexpressing pbcR. The activation of a cryptic gene cluster by overexpression of its putative Zn(II)(2)Cys(6)-type transcription factor led to discovery of a novel secondary metabolite in Aspergillus nidulans. Quantitative real-time PCR and DNA array analysis allowed us to predict the borders of the biosynthetic gene cluster. Furthermore, we identified a novel fungal pimaradiene cyclase gene as well as genes encoding 3-hydroxy-3-methyl-glutaryl-coenzyme A (HMG-CoA) reductase and a geranylgeranyl pyrophosphate (GGPP) synthase. None of these genes have been previously implicated in the biosynthesis of terpenes in Aspergillus nidulans. These results identify the first Aspergillus nidulans diterpene gene cluster and suggest a biosynthetic pathway for ent-pimara-8(14),15-diene.
真菌次生代谢产物是医学上有用化合物的丰富来源,因为它们具有药物和毒性特性。真菌基因组测序揭示了许多次生代谢物基因簇,但这些生物合成途径的许多产物仍然未知,因为在正常实验室条件下,这些簇基因的表达通常是沉默的。因此,要发现新的代谢物,找到诱导这些沉默生物合成簇中基因表达的方法很重要。我们通过基因组挖掘预测了一个生物合成基因簇,在构巢曲霉中发现了一种新型次生代谢物。鉴定了一个 Zn(II)(2)Cys(6) 型转录因子 PbcR,并证明了其作为预测基因簇的途径特异性激活子的作用。pbcR 的过表达上调了鉴定出的簇中七个基因的转录,并导致二萜化合物的产生,该化合物用 GC/MS 鉴定为 ent-pimara-8(14),15-diene。过表达 pbcR 的菌株的形态也发生了变化。通过过表达其假定的 Zn(II)(2)Cys(6) 型转录因子激活隐匿基因簇,导致构巢曲霉中发现一种新型次生代谢物。定量实时 PCR 和 DNA 阵列分析使我们能够预测生物合成基因簇的边界。此外,我们还鉴定了一个新型真菌 pimaradiene 环化酶基因以及编码 3-羟基-3-甲基戊二酰辅酶 A (HMG-CoA) 还原酶和香叶基香叶基焦磷酸 (GGPP) 合酶的基因。这些基因以前都没有被认为与构巢曲霉萜类化合物的生物合成有关。这些结果确定了第一个构巢曲霉二萜基因簇,并提出了 ent-pimara-8(14),15-diene 的生物合成途径。